
Annual report 2023
added 12-06-2025
Natura &Co Holding S.A. Revenue 2011-2026 | NTCO
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Natura &Co Holding S.A.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.7 B | 29.2 B | 31.7 B | 36.9 B | 14.4 B | 13.4 B | 9.85 B | - | - | - | - | - | - |
All numbers in BRL currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.9 B | 9.85 B | 23.2 B |
Quarterly Revenue Natura &Co Holding S.A.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | 6.99 B | - | - | - | 3.4 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in BRL currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.99 B | 3.4 B | 5.2 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Household products industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Estée Lauder Companies
EL
|
14.3 B | $ 72.03 | -9.14 % | $ 25.9 B | ||
|
LifeVantage Corporation
LFVN
|
229 M | $ 4.49 | -1.1 % | $ 55 M | ||
|
The Clorox Company
CLX
|
7.1 B | $ 104.82 | -0.96 % | $ 12.9 B | ||
|
Mannatech, Incorporated
MTEX
|
132 M | $ 6.86 | - | $ 12.8 M | ||
|
Nu Skin Enterprises
NUS
|
1.73 B | $ 7.28 | 1.11 % | $ 359 M | ||
|
Edgewell Personal Care Company
EPC
|
2.25 B | $ 19.29 | -1.13 % | $ 959 M | ||
|
Nature's Sunshine Products
NATR
|
480 M | $ 23.4 | -0.93 % | $ 421 M | ||
|
Inter Parfums
IPAR
|
1.49 B | $ 90.94 | 0.28 % | $ 2.92 B | ||
|
Kimberly-Clark Corporation
KMB
|
4.08 B | $ 99.5 | 0.05 % | $ 33 B | ||
|
The Procter & Gamble Company
PG
|
84.3 B | $ 144.76 | 0.53 % | $ 340 B | ||
|
Newell Brands
NWL
|
7.2 B | $ 3.57 | -0.42 % | $ 1.49 B | ||
|
Helen of Troy Limited
HELE
|
1.91 B | $ 15.08 | -0.23 % | $ 347 M | ||
|
Coty
COTY
|
5.89 B | $ 2.13 | -0.7 % | $ 1.86 B | ||
|
Church & Dwight Co.
CHD
|
6.2 B | $ 94.48 | -0.18 % | $ 22.9 B | ||
|
Colgate-Palmolive Company
CL
|
20.4 B | $ 85.28 | 0.15 % | $ 69 B | ||
|
Spectrum Brands Holdings
SPB
|
2.81 B | $ 73.91 | 1.71 % | $ 1.9 B | ||
|
United-Guardian
UG
|
10.9 M | $ 6.25 | -0.32 % | $ 28.7 M | ||
|
Unilever PLC
UL
|
50.5 B | $ 61.03 | -0.1 % | $ 132 B | ||
|
Hims & Hers Health
HIMS
|
2.35 B | $ 21.62 | -3.95 % | $ 4.86 B | ||
|
USANA Health Sciences
USNA
|
925 M | $ 17.34 | -1.14 % | $ 321 M | ||
|
Dogness (International) Corporation
DOGZ
|
27.1 M | $ 1.5 | -1.64 % | $ 50.6 M | ||
|
Revlon
REV
|
2.08 B | - | -4.41 % | $ 212 M | ||
|
e.l.f. Beauty
ELF
|
321 M | $ 69.72 | -3.06 % | $ 3.82 B | ||
|
Acme United Corporation
ACU
|
197 M | $ 44.9 | -0.22 % | $ 170 M |